表紙：肺がん治療市場：タイプ別、治療別、エンドユーザー別、世界予測、2023-2032年

市場調査レポート

商品コード

1287292

肺がん治療市場：タイプ別、治療別、エンドユーザー別、世界予測、2023-2032年

Lung Cancer Treatment Market - By Type (Carcinoid, Non-small & Small Cell), By Therapy [(Radiation, Immunotherapy (Durvalumab), Targeted (Bevacizumab), Chemotherapy], By End-user (Hospitals, Specialty Clinics, Homecare), Global Forecast, 2023-2032

出版日: 2023年05月16日 | 発行: Global Market Insights Inc.

| ページ情報: 英文 182 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF & Excel (Single User License)

USD 4,850 762,129円

レポートPDFおよびExcelを1名様のみがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は可能ですが、印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Multi User License)

USD 5,350 840,699円

レポートPDFおよびExcelを5名様までがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は可能ですが、印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Enterprise User License)

USD 8,350 1,312,119円

レポートPDFおよびExcelを同一企業内のすべての方にご利用頂けるライセンスです。 100％子会社は同一企業とみなされます。 PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は可能ですが、印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

肺がん治療の世界市場規模は2023-2032年に大きく成長します。

世界の都市化と工業化の加速による大気汚染レベルの上昇は、肺がんの発生率の上昇をもたらし、その治療の必要性を高めています。WHOによると、環境大気汚染は肺がんによる死亡の16%につながると予測されており、大気汚染は世界の肺がんによる死亡の約29%に関与している可能性があります。このような疾病負担の増加により、さらなる合併症を防ぐための早期診断・治療に対する意識が高まり、市場の成長に寄与しています。

肺がん治療市場全体は、タイプ、治療法、エンドユーザー、地域によって区分されます。

タイプ別では、カルチノイドの市場シェアが2032年まで大きな伸びを示すと予想されます。肺がんの有病率の上昇とそれに伴う高い死亡率により、その治療に対するニーズが高まっています。米国がん協会によると、米国では毎年約2,000～4,500の肺カルチノイド腫瘍が報告されています。さらに、診断技術の向上とカルチノイド腫瘍に対する認識の高まりにより、この疾患の治療を受ける患者数が増加し、市場収益に寄与しています。

治療法では、化学療法による肺がん治療の市場規模が2032年まで大きな伸びを示すでしょう。ゲノミクスと分子プロファイリングの進歩は、化学療法における個別化医療を可能にしました。患者の腫瘍を分子レベルで分析することで、医師はがんの成長を促進する特定の遺伝子変異やバイオマーカーを特定することができます。この情報は、化学療法レジメンをその特定の異常をターゲットとして調整するのに役立ち、治療効果を高める。

エンドユーザー別では、専門クリニック分野の肺がん治療市場が2023年から2032年にかけて高い成長を遂げると予想されます。最先端の診断機器が充実しているため、専門クリニックは好んで利用されるヘルスケアプロバイダーとなっています。また、これらの施設は、患者のニーズに合わせた個別化医療を提供するのに適した位置にあります。これらの施設では、包括的な評価、分子プロファイリング、臨床試験へのアクセスなどを提供し、患者が最も適切で効果的な治療オプションを受けられるようにします。

地域別では、欧州の肺がん治療産業は2023年から2032年にかけて、まずまずのCAGRで成長すると思われます。肺がんの罹患率が高いことから、同地域ではその治療の必要性が高まっています。また、Boehringer Ingelheim International GmbH、Merck KGaAなどの業界競合他社が、肺がんの高度な治療法の開拓に絶えず力を入れていることも、この地域の市場成長にプラスの影響を与えています。さらに、この地域の既存のヘルスケアインフラの急速な拡大が、2032年までの業界の収益源を刺激すると考えられます。

業界のエコシステム分析
業界への影響要因
- 促進要因
  - 世界の肺がん有病率の増加
  - タバコを吸う傾向の高まり
  - 急速な工業化に伴う大気汚染レベルの上昇
  - がんの早期診断の重要性の高まり
  - 肺がん治療における技術的進歩の増加
  - 肺がん治療に対する保険償還の利用可能性
- 業界の潜在的リスク＆課題
  - 肺がん治療の高額な費用
  - 薬剤や治療法の副作用
成長性分析
COVID-19の影響分析
臨床試験分析
規制状況
- 米国
- 欧州
テクノロジー情勢
ポーター分析
PESTEL分析

第4章競合情勢、2022年

イントロダクション
競合ダッシュボード、2022年
企業マトリックス分析、2022年
企業シェア分析、2022年
競合のポジショニング・マトリックス、2022年
戦略的展望マトリクス、2022年

第5章肺がん治療市場の推定・予測：タイプ別

主要動向、タイプ別
非小細胞肺がん
小細胞肺がん
カルチノイド

第6章肺がん治療市場の推定・予測：治療別

主な動向、治療法別
放射線療法
免疫療法
標的治療
化学療法
その他の治療法

第7章肺がん治療市場の推定・予測：エンドユーザー別

主要動向、エンドユーザー別
病院
専門クリニック
在宅医療
その他エンドユーザー

第8章肺がん治療薬の市場規模・予測：地域別

主な動向、地域別
北米
- 米国
- カナダ
欧州
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- その他欧州
アジア太平洋地域
- 日本
- 中国
- インド
- オーストラリア
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- メキシコ
- その他ラテンアメリカ地域
MEA
- 南アフリカ
- サウジアラビア
- その他中東とアフリカ

第9章企業プロファイル

Merck KGaA
ONO PHARMACEUTICAL CO., LTD.
Boehringer Ingelheim International GmbH
GlaxoSmithKline plc.
Pfizer Inc.
Johnson & Johnson Services, Inc.
AstraZeneca
Takeda Pharmaceutical Company Limited
Church & Dwight Co., Inc.
Sun Pharmaceutical Industries Ltd.Takara Bio Inc.

図表

Data Tables

TABLE 1. Product mapping
TABLE 2. Market revenue, by type (2022)
TABLE 3. Market revenue, by therapy (2022)
TABLE 4. Market share, by end-user (2022)
TABLE 5. Market share, by region (2022)
TABLE 6. Global lung cancer treatment market size, by region, 2018 - 2022 (USD Million)
TABLE 7. Global lung cancer treatment market size, by region, 2023 - 2032 (USD Million)
TABLE 8. Global lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 9. Global lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 10. Global lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 11. Global lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 12. Global lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 13. Global lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 14. Industry impact forces
TABLE 15. Non-small cell lung cancer market size, 2018 - 2022 (USD Million)
TABLE 16. Non-small cell lung cancer market size, 2023 - 2032 (USD Million)
TABLE 17. Small cell lung cancer market size, 2018 - 2022 (USD Million)
TABLE 18. Small cell lung cancer market size, 2023 - 2032 (USD Million)
TABLE 19. Carcinoid size, 2018 - 2022 (USD Million)
TABLE 20. Carcinoid size, 2023 - 2032 (USD Million)
TABLE 21. Radiation therapy, market size, 2018 - 2022 (USD Million)
TABLE 22. Radiation therapy, market size, 2023 - 2032 (USD Million)
TABLE 23. External beam radiation therapy market size, 2018 - 2022 (USD Million)
TABLE 24. External beam radiation therapy market size, 2023 - 2032 (USD Million)
TABLE 25. Internal beam radiation therapy market size, 2018 - 2022 (USD Million)
TABLE 26. Internal beam radiation therapy market size, 2023 - 2032 (USD Million)
TABLE 27. Systemic radiation therapy market size, 2018 - 2022 (USD Million)
TABLE 28. Systemic radiation therapy market size, 2023 - 2032 (USD Million)
TABLE 29. Immunotherapy therapy market size, 2018 - 2022 (USD Million)
TABLE 30. Immunotherapy therapy market size, 2023 - 2032 (USD Million)
TABLE 31. Durvalumab market size, 2018 - 2022 (USD Million)
TABLE 32. Durvalumab market size, 2023 - 2032 (USD Million)
TABLE 33. Nivolumab market size, 2018 - 2022 (USD Million)
TABLE 34. Nivolumab market size, 2023 - 2032 (USD Million)
TABLE 35. Atezolizumab market size, 2018 - 2022 (USD Million)
TABLE 36. Atezolizumab market size, 2023 - 2032 (USD Million)
TABLE 37. Pembrolizumab market size, 2018 - 2022 (USD Million)
TABLE 38. Pembrolizumab market size, 2023 - 2032 (USD Million)
TABLE 39. Other immunotherapies market size, 2018 - 2022 (USD Million)
TABLE 40. Other immunotherapies market size, 2023 - 2032 (USD Million)
TABLE 41. Targeted therapy market size, 2018 - 2022 (USD Million)
TABLE 42. Targeted therapy market size, 2023 - 2032 (USD Million)
TABLE 43. Bevacizumab market size, 2018 - 2022 (USD Million)
TABLE 44. Bevacizumab market size, 2023 - 2032 (USD Million)
TABLE 45. Dabrafenib/Trametinib market size, 2018 - 2022 (USD Million)
TABLE 46. Dabrafenib/Trametinib market size, 2023 - 2032 (USD Million)
TABLE 47. Erlotinib hydrochloride market size, 2018 - 2022 (USD Million)
TABLE 48. Erlotinib hydrochloride market size, 2023 - 2032 (USD Million)
TABLE 49. Osimertinib market size, 2018 - 2022 (USD Million)
TABLE 50. Osimertinib market size, 2023 - 2032 (USD Million)
TABLE 51. Other targeted therapies market size, 2018 - 2022 (USD Million)
TABLE 52. Other targeted therapies market size, 2023 - 2032 (USD Million)
TABLE 53. Chemotherapy market size, 2018 - 2022 (USD Million)
TABLE 54. Chemotherapy market size, 2023 - 2032 (USD Million)
TABLE 55. Other therapies market size, 2018 - 2022 (USD Million)
TABLE 56. Other therapies market size, 2023 - 2032 (USD Million)
TABLE 57. Hospitals market size, 2018 - 2022 (USD Million)
TABLE 58. Hospitals market size, 2023 - 2032 (USD Million)
TABLE 59. Specialty clinics market size, 2018 - 2022 (USD Million)
TABLE 60. Specialty clinics market size, 2023 - 2032 (USD Million)
TABLE 61. Homecare market size, 2018 - 2022 (USD Million)
TABLE 62. Homecare market size, 2023 - 2032 (USD Million)
TABLE 63. Other end-users market size, 2018 - 2022 (USD Million)
TABLE 64. Other end-users market size, 2023 - 2032 (USD Million)
TABLE 65. North America lung cancer treatment market size, by country, 2018 - 2022 (USD Million)
TABLE 66. North America lung cancer treatment market size, by country, 2023 - 2032 (USD Million)
TABLE 67. North America lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 68. North America lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 69. North America lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 70. North America lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 71. North America lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 72. North America lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 73. North America lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 74. North America lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 75. North America lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 76. North America lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 77. North America lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 78. North America lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 79. U.S. lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 80. U.S. lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 81. U.S. lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 82. U.S. lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 83. U.S. lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 84. U.S. lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 85. U.S. lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 86. U.S. lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 87. U.S. lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 88. U.S. lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 89. U.S. lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 90. U.S. lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 91. Canada lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 92. Canada lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 93. Canada lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 94. Canada lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 95. Canada lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 96. Canada lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 97. Canada lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 98. Canada lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 99. Canada lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 100. Canada lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 101. Canada lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 102. Canada lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 103. Europe lung cancer treatment market size, by country, 2018 - 2022 (USD Million)
TABLE 104. Europe lung cancer treatment market size, by country, 2023 - 2032 (USD Million)
TABLE 105. Europe lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 106. Europe lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 107. Europe lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 108. Europe lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 109. Europe lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 110. Europe lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 111. Europe lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 112. Europe lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 113. Europe lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 114. Europe lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 115. Europe lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 116. Europe lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 117. Germany lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 118. Germany lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 119. Germany lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 120. Germany lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 121. Germany lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 122. Germany lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 123. Germany lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 124. Germany lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 125. Germany lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 126. Germany lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 127. Germany lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 128. Germany lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 129. UK lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 130. UK lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 131. UK lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 132. UK lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 133. UK lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 134. UK lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 135. UK lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 136. UK lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 137. UK lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 138. UK lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 139. UK lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 140. UK lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 141. France lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 142. France lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 143. France lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 144. France lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 145. France lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 146. France lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 147. France lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 148. France lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 149. France lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 150. France lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 151. France lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 152. France lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 153. Italy lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 154. Italy lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 155. Italy lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 156. Italy lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 157. Italy lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 158. Italy lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 159. Italy lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 160. Italy lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 161. Italy lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 162. Italy lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 163. Italy lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 164. Italy lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 165. Spain lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 166. Spain lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 167. Spain lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 168. Spain lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 169. Spain lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 170. Spain lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 171. Spain lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 172. Spain lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 173. Spain lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 174. Spain lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 175. Spain lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 176. Spain lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 177. Rest of Europe lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 178. Rest of Europe lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 179. Rest of Europe lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 180. Rest of Europe lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 181. Rest of Europe lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 182. Rest of Europe lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 183. Rest of Europe lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 184. Rest of Europe lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 185. Rest of Europe lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 186. Rest of Europe lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 187. Rest of Europe lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 188. Rest of Europe lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 189. Asia Pacific lung cancer treatment market size, by country, 2018 - 2022 (USD Million)
TABLE 190. Asia Pacific lung cancer treatment market size, by country, 2023 - 2032 (USD Million)
TABLE 191. Asia Pacific lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 192. Asia Pacific lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 193. Asia Pacific lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 194. Asia Pacific lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 195. Asia Pacific lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 196. Asia Pacific lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 197. Asia Pacific lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 198. Asia Pacific lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 199. Asia Pacific lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 200. Asia Pacific lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 201. Asia Pacific lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 202. Asia Pacific lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 203. China lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 204. China lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 205. China lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 206. China lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 207. China lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 208. China lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 209. China lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 210. China lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 211. China lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 212. China lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 213. China lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 214. China lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 215. Japan lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 216. Japan lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 217. Japan lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 218. Japan lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 219. Japan lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 220. Japan lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 221. Japan lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 222. Japan lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 223. Japan lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 224. Japan lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 225. Japan lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 226. Japan lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 227. India lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 228. India lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 229. India lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 230. India lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 231. India lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 232. India lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 233. India lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 234. India lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 235. India lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 236. India lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 237. India lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 238. India lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 239. Australia lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 240. Australia lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 241. Australia lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 242. Australia lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 243. Australia lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 244. Australia lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 245. Australia lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 246. Australia lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 247. Australia lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 248. Australia lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 249. Australia lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 250. Australia lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 251. Rest of Asia Pacific lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 252. Rest of Asia Pacific lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 253. Rest of Asia Pacific lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 254. Rest of Asia Pacific lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 255. Rest of Asia Pacific lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 256. Rest of Asia Pacific lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 257. Rest of Asia Pacific lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 258. Rest of Asia Pacific lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 259. Rest of Asia Pacific lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 260. Rest of Asia Pacific lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 261. Rest of Asia Pacific lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 262. Rest of Asia Pacific lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 263. Latin America lung cancer treatment market size, by country, 2018 - 2022 (USD Million)
TABLE 264. Latin America lung cancer treatment market size, by country, 2023 - 2032 (USD Million)
TABLE 265. Latin America lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 266. Latin America lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 267. Latin America lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 268. Latin America lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 269. Latin America lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 270. Latin America lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 271. Latin America lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 272. Latin America lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 273. Latin America lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 274. Latin America lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 275. Latin America lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 276. Latin America lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 277. Brazil lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 278. Brazil lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 279. Brazil lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 280. Brazil lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 281. Brazil lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 282. Brazil lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 283. Brazil lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 284. Brazil lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 285. Brazil lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 286. Brazil lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 287. Brazil lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 288. Brazil lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 289. Mexico lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 290. Mexico lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 291. Mexico lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 292. Mexico lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 293. Mexico lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 294. Mexico lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 295. Mexico lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 296. Mexico lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 297. Mexico lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 298. Mexico lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 299. Mexico lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 300. Mexico lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 301. Rest of Latin America lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 302. Rest of Latin America lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 303. Rest of Latin America lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 304. Rest of Latin America lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 305. Rest of Latin America lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 306. Rest of Latin America lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 307. Rest of Latin America lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 308. Rest of Latin America lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 309. Rest of Latin America lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 310. Rest of Latin America lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 311. Rest of Latin America lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 312. Rest of Latin America lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 313. Middle East & Africa lung cancer treatment market size, by country, 2018 - 2022 (USD Million)
TABLE 314. Middle East & Africa lung cancer treatment market size, by country, 2023 - 2032 (USD Million)
TABLE 315. Middle East & Africa lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 316. Middle East & Africa lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 317. Middle East & Africa lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 318. Middle East & Africa lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 319. Middle East & Africa lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 320. Middle East & Africa lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 321. Middle East & Africa lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 322. Middle East & Africa lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 323. Middle East & Africa lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 324. Middle East & Africa lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 325. Middle East & Africa lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 326. Middle East & Africa lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 327. South Africa lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 328. South Africa lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 329. South Africa lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 330. South Africa lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 331. South Africa lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 332. South Africa lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 333. South Africa lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 334. South Africa lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 335. South Africa lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 336. South Africa lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 337. South Africa lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 338. South Africa lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 339. Saudi Arabia lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 340. Saudi Arabia lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 341. Saudi Arabia lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 342. Saudi Arabia lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 343. Saudi Arabia lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 344. Saudi Arabia lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 345. Saudi Arabia lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 346. Saudi Arabia lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 347. Saudi Arabia lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 348. Saudi Arabia lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 349. Saudi Arabia lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 350. Saudi Arabia lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 351. Rest of Middle East & Africa lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
TABLE 352. Rest of Middle East & Africa lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
TABLE 353. Rest of Middle East & Africa lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
TABLE 354. Rest of Middle East & Africa lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
TABLE 355. Rest of Middle East & Africa lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
TABLE 356. Rest of Middle East & Africa lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
TABLE 357. Rest of Middle East & Africa lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
TABLE 358. Rest of Middle East & Africa lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
TABLE 359. Rest of Middle East & Africa lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
TABLE 360. Rest of Middle East & Africa lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
TABLE 361. Rest of Middle East & Africa lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 362. Rest of Middle East & Africa lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)

Charts & Figures

FIG. 1 GMI report coverage: Critical research elements
FIG. 2 Industry segmentation
FIG. 3 Top-down approach
FIG. 4 Market estimation and forecast methodology
FIG. 5 Market forecasting methodology
FIG. 6 Breakdown of primary participants
FIG. 7 Lung Cancer Treatment industry 360 degree synopsis, 2018 - 2032
FIG. 8 Growth potential analysis, by type
FIG. 9 Growth potential analysis, by therapy
FIG. 10 Growth potential analysis, by end-user
FIG. 11 Porter's analysis
FIG. 12 PESTEL analysis
FIG. 13 Competitive dashboard, 2022
FIG. 14 Company matrix analysis, 2022
FIG. 15 Company market share analysis, 2022
FIG. 16 Competitive positioning matrix, 2022
FIG. 17 Strategic outlook matrix, 2022

Product Code: 5708

Global Lung Cancer Treatment Market size will grow substantially during 2023-2032. Rising air pollution levels due to accelerating urbanization and industrial growth worldwide have resulted in increased incidences of lung cancer, bolstering the need for its treatment. As per the WHO, ambient air pollution is projected to lead to 16% of lung cancer deaths, while air pollution may be responsible for around 29% of the deaths caused by lung cancer globally. The increasing disease burden has bolstered awareness about its early diagnosis and treatment to prevent further complications, contributing to market growth.

The overall lung cancer treatment market is segmented based on type, therapy, end-user, and region.

Based on type, the market share from the carcinoid segment will depict significant growth through 2032. Growing prevalence of lung cancer and high mortality rate associated with it has increased the need for its treatment. According to the American Cancer Society, the U.S. reports around 2,000 to 4,500 lung carcinoid tumors every year. Moreover, improved diagnostic techniques and the rising awareness of carcinoid tumors have propelled the number of patients undergoing treatment of this condition, thus, adding to market revenue.

In terms of therapy, the lung cancer treatment market value from the chemotherapy segment will accrue significant gains through 2032. Advances in genomics and molecular profiling have enabled personalized medicine in chemotherapy. By analyzing a patient's tumor at a molecular level, doctors can identify specific genetic mutations or biomarkers that drive the cancer's growth. This information helps tailor the chemotherapy regimen to target those specific abnormalities, increasing treatment effectiveness.

Based on end-user, the lung cancer treatment market from the specialty clinics segment will observe appreciable growth over 2023-2032. High availability of cutting-edge diagnostic equipment has made specialty clinics a preferred healthcare provider. Additionally, these facilities are well-positioned to provide personalized care tailored to specific patient needs. They offer comprehensive evaluations, molecular profiling, and access to clinical trials, ensuring that patients receive the most appropriate and effective treatment options.

Regionally, Europe lung cancer treatment industry will grow at a decent CAGR from 2023 to 2032. High incidence rate of lung cancer has increased the need for its treatment in the region. Moreover, a strong presence of industry contenders such as Boehringer Ingelheim International GmbH, Merck KGaA, and others constantly focusing on developing advanced treatment options for lung cancer is positively impacting the regional market growth. Additionally, the rapid expansion of the existing healthcare infrastructure in the region will stimulate industry revenue streams through 2032.

Chapter 1 Methodology & Scope

1.1 Industry coverage
1.2 Market definitions
1.3 Base estimates and calculations
1.4 Forecast calculations
1.5 Data sources
1.6 Data validation
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Lung Cancer Treatment industry 360 degree synopsis, 2018 - 2032 (USD Million)
- 2.1.1 Business trends
- 2.1.2 Type trends
- 2.1.3 By Therapy trends
- 2.1.4 End-user trends
- 2.1.5 Regional trends

Chapter 3 Lung Cancer Treatment Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of lung cancer across the globe
  - 3.2.1.2 The growing trend of smoking tobacco
  - 3.2.1.3 Rising levels of air pollution due to rapid industrialization
  - 3.2.1.4 Increasing emphasis on early diagnosis of cancers
  - 3.2.1.5 Rising technological advancements in lung cancer treatment
  - 3.2.1.6 Availability of reimbursement for lung cancer treatment
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 The high cost of lung cancer treatments
  - 3.2.2.2 Side effects of drugs and therapies
3.3 Growth potential analysis
- 3.3.1 By type
- 3.3.2 By therapy
- 3.3.3 By end-user
3.4 COVID-19 impact analysis
3.5 Clinical trial analysis
3.6 Regulatory landscape
- 3.6.1 U.S.
- 3.6.2 Europe
3.7 Technology landscape
3.8 Porter's analysis
3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Competitive dashboard, 2022
4.3 Company matrix analysis, 2022
4.4 Company market share analysis, 2022
4.5 Competitive positioning matrix, 2022
4.6 Strategic outlook matrix, 2022

Chapter 5 Lung Cancer Treatment Market Estimates and Forecast, By Type (USD Million)

5.1 Key trends, by type
5.2 Non-small cell lung cancer
5.3 Small cell lung cancer
5.4 Carcinoid

Chapter 6 Lung Cancer Treatment Market Estimates and Forecast, By Therapy (USD Million)

6.1 Key trends, by therapy
6.2 Radiation therapy
6.3 Immunotherapy
6.4 Targeted therapy
6.5 Chemotherapy
6.6 Other therapies

Chapter 7 Lung Cancer Treatment Market Estimates and Forecast, By End-user (USD Million)

7.1 Key trends, by end-user
7.2 Hospitals
7.3 Specialty clinics
7.4 Homecare
7.5 Other end-users

Chapter 8 Lung Cancer Treatment Market Size and Forecast, By Region (USD Million)

8.1 Key trends, by region
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Rest of Latin America
8.6 MEA
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 Rest of Middle East & Africa

Chapter 9 Company Profiles

9.1 Merck KGaA
9.2 ONO PHARMACEUTICAL CO., LTD.
9.3 Boehringer Ingelheim International GmbH
9.4 GlaxoSmithKline plc.
9.5 Pfizer Inc.
9.6 Johnson & Johnson Services, Inc.
9.7 AstraZeneca
9.8 Takeda Pharmaceutical Company Limited
9.9 Church & Dwight Co., Inc.
9.10 Sun Pharmaceutical Industries Ltd.Takara Bio Inc.

肺がん治療市場：タイプ別、治療別、エンドユーザー別、世界予測、2023-2032年

Lung Cancer Treatment Market - By Type (Carcinoid, Non-small & Small Cell), By Therapy [(Radiation, Immunotherapy (Durvalumab), Targeted (Bevacizumab), Chemotherapy], By End-user (Hospitals, Specialty Clinics, Homecare), Global Forecast, 2023-2032

目次

第1章調査手法とスコープ

第2章エグゼクティブサマリー

第3章肺がん治療業界の洞察

第4章競合情勢、2022年

第5章肺がん治療市場の推定・予測：タイプ別

第6章肺がん治療市場の推定・予測：治療別

第7章肺がん治療市場の推定・予測：エンドユーザー別

第8章肺がん治療薬の市場規模・予測：地域別

第9章企業プロファイル

Data Tables

Charts & Figures

Table of Contents

Chapter 1 Methodology & Scope

Chapter 2 Executive Summary

Chapter 3 Lung Cancer Treatment Industry Insights

Chapter 4 Competitive Landscape, 2022

Chapter 5 Lung Cancer Treatment Market Estimates and Forecast, By Type (USD Million)

Chapter 6 Lung Cancer Treatment Market Estimates and Forecast, By Therapy (USD Million)

Chapter 7 Lung Cancer Treatment Market Estimates and Forecast, By End-user (USD Million)

Chapter 8 Lung Cancer Treatment Market Size and Forecast, By Region (USD Million)

Chapter 9 Company Profiles

肺がん治療市場：タイプ別、治療別、エンドユーザー別、世界予測、2023-2032年

Lung Cancer Treatment Market - By Type (Carcinoid, Non-small & Small Cell), By Therapy [(Radiation, Immunotherapy (Durvalumab), Targeted (Bevacizumab), Chemotherapy], By End-user (Hospitals, Specialty Clinics, Homecare), Global Forecast, 2023-2032

目次

第1章 調査手法とスコープ

第2章 エグゼクティブサマリー

第3章 肺がん治療業界の洞察

第4章 競合情勢、2022年

第5章 肺がん治療市場の推定・予測：タイプ別

第6章 肺がん治療市場の推定・予測：治療別

第7章 肺がん治療市場の推定・予測：エンドユーザー別

第8章 肺がん治療薬の市場規模・予測：地域別

第9章 企業プロファイル

Data Tables

Charts & Figures

Table of Contents

Chapter 1 Methodology & Scope

Chapter 2 Executive Summary

Chapter 3 Lung Cancer Treatment Industry Insights

Chapter 4 Competitive Landscape, 2022

Chapter 5 Lung Cancer Treatment Market Estimates and Forecast, By Type (USD Million)

Chapter 6 Lung Cancer Treatment Market Estimates and Forecast, By Therapy (USD Million)

Chapter 7 Lung Cancer Treatment Market Estimates and Forecast, By End-user (USD Million)

Chapter 8 Lung Cancer Treatment Market Size and Forecast, By Region (USD Million)

Chapter 9 Company Profiles

第1章調査手法とスコープ

第2章エグゼクティブサマリー

第3章肺がん治療業界の洞察

第4章競合情勢、2022年

第5章肺がん治療市場の推定・予測：タイプ別

第6章肺がん治療市場の推定・予測：治療別

第7章肺がん治療市場の推定・予測：エンドユーザー別

第8章肺がん治療薬の市場規模・予測：地域別

第9章企業プロファイル